Logo image of GBBK

GLOBAL BLOCKCHAIN ACQUISITIO (GBBK) Stock Fundamental Analysis

NASDAQ:GBBK - Nasdaq - US37961B1044 - Common Stock - Currency: USD

11.36  -0.06 (-0.53%)

Fundamental Rating

1

Taking everything into account, GBBK scores 1 out of 10 in our fundamental rating. GBBK was compared to 0 industry peers in the Unkown industry. GBBK has a bad profitability rating. Also its financial health evaluation is rather negative. GBBK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GBBK has reported negative net income.
GBBK had a negative operating cash flow in the past year.
GBBK Yearly Net Income VS EBIT VS OCF VS FCFGBBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 1M -1M 2M -2M 3M

1.2 Ratios

Industry RankSector Rank
ROA -1.97%
ROE -2.99%
ROIC N/A
ROA(3y)3.62%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GBBK Yearly ROA, ROE, ROICGBBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 5 10

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for GBBK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GBBK Yearly Profit, Operating, Gross MarginsGBBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for GBBK has been reduced compared to 1 year ago.
There is no outstanding debt for GBBK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GBBK Yearly Shares OutstandingGBBK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M
GBBK Yearly Total Debt VS Total AssetsGBBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M

2.2 Solvency

GBBK has an Altman-Z score of 11.49. This indicates that GBBK is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.17 indicates that GBBK is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 11.49
ROIC/WACCN/A
WACCN/A
GBBK Yearly LT Debt VS Equity VS FCFGBBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.08 indicates that GBBK may have some problems paying its short term obligations.
A Quick Ratio of 0.08 indicates that GBBK may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
GBBK Yearly Current Assets VS Current LiabilitesGBBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for GBBK have decreased strongly by -115.58% in the last year.
EPS 1Y (TTM)-115.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-149.38%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GBBK Yearly Revenue VS EstimatesGBBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
GBBK Yearly EPS VS EstimatesGBBK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GBBK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GBBK Price Earnings VS Forward Price EarningsGBBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GBBK Per share dataGBBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GBBK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GLOBAL BLOCKCHAIN ACQUISITIO

NASDAQ:GBBK (3/7/2025, 8:00:01 PM)

11.36

-0.06 (-0.53%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners10.92%
Inst Owner Change-30.28%
Ins OwnersN/A
Ins Owner Change0%
Market Cap61.91M
AnalystsN/A
Price TargetN/A
Short Float %0.33%
Short Ratio0.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 10.94
P/tB 10.94
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0
BVpS1.04
TBVpS1.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.97%
ROE -2.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.62%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z 11.49
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-115.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-149.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-73.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.03%
OCF growth 3YN/A
OCF growth 5YN/A